APA

Garban F., Guyard A., Labussière H., Bulabois C., Marchand T., Mounier C., Caillot D., Bay J., Coiteux V., Schmidt-Tanguy A., Le Niger C., Robin C., Ladaique P., Lapusan S., Deconinck E., Rolland C., Foote A. M., François A., Jacquot C., Tardivel R., Tiberghien P. & Bosson J. (20190913). Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial. : JAMA oncology.

Chicago

Garban Frédéric, Guyard Audrey, Labussière Helene, Bulabois Claude-Eric, Marchand Tony, Mounier Christiane, Caillot Denis, Bay Jacques-Olivier, Coiteux Valérie, Schmidt-Tanguy Aline, Le Niger Catherine, Robin Christine, Ladaique Patrick, Lapusan Simona, Deconinck Eric, Rolland Carole, Foote Alison M, François Anne, Jacquot Chantal, Tardivel René, Tiberghien Pierre and Bosson Jean-Luc. 20190913. Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial. : JAMA oncology.

Harvard

Garban F., Guyard A., Labussière H., Bulabois C., Marchand T., Mounier C., Caillot D., Bay J., Coiteux V., Schmidt-Tanguy A., Le Niger C., Robin C., Ladaique P., Lapusan S., Deconinck E., Rolland C., Foote A. M., François A., Jacquot C., Tardivel R., Tiberghien P. and Bosson J. (20190913). Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial. : JAMA oncology.

MLA

Garban Frédéric, Guyard Audrey, Labussière Helene, Bulabois Claude-Eric, Marchand Tony, Mounier Christiane, Caillot Denis, Bay Jacques-Olivier, Coiteux Valérie, Schmidt-Tanguy Aline, Le Niger Catherine, Robin Christine, Ladaique Patrick, Lapusan Simona, Deconinck Eric, Rolland Carole, Foote Alison M, François Anne, Jacquot Chantal, Tardivel René, Tiberghien Pierre and Bosson Jean-Luc. Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial. : JAMA oncology. 20190913.